SEI Investments
RCUS icon

SEI Investments’s Arcus Biosciences RCUS Stock Holding History

SEI Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Hold
10,295
– – ﹤0.01% 2936
2025
Q4 		$245K Buy
+10,295
New +$210K ﹤0.01% 2819
2022
Q2 		– Sell
-45,343
Closed -$1.43M – 2704
2022
Q1 		$1.43M Sell
45,343
-4,816
-10% -$161K ﹤0.01% 1676
2021
Q4 		$2.03M Buy
+50,159
New +$1.95M ﹤0.01% 1581
2020
Q3 		– Sell
-11,938
Closed -$295K – 2489
2020
Q2 		$295K Buy
+11,938
New +$322K ﹤0.01% 2091

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

SEI Investments's RCUS Position: Q1 2026 in Review

SEI Investments held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 10,295 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #2936.

SEI Investments first reported a position in RCUS in Q2 2020 and has held it in 5 quarters since. The position peaked at $2.03M in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • SEI Investments held 10,295 shares of Arcus Biosciences worth $222K as of Q1 2026.
  • SEI Investments left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2936 holding.
  • SEI Investments first reported a position in Arcus Biosciences in Q2 2020 and has held it in 5 quarters since.
  • SEI Investments's Arcus Biosciences position peaked at $2.03M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.